FDA Approves Novel Non-Opioid Treatment for Moderate to …
3 days ago · The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
4 days ago · BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has …
FDA approves first new type of pain medication in 25 years
3 days ago · The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50 …
FDA Approves Journavx (suzetrigine), a First-in-Class Treatment …
BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved …
FDA approves first non-opioid pain medicine in more than 20 years
2 days ago · But, a report from The Institute for Clinical and Economic Review in December estimated that suzetrigine would be "slightly cost-saving" relative to opioids if the price was set …
FDA approves painkiller designed to eliminate risks of addiction ...
3 days ago · This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication. (Vertex Pharmaceuticals via AP) Read …
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine …
Jul 30, 2024 · The FDA has granted suzetrigine priority review and assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025. Suzetrigine has already been …
FDA Approves Novel Non-Opioid Treatment for Moderate to …
3 days ago · /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic,...
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk …
3 days ago · Suzetrigine’s price, though, is much higher than that of acetaminophen plus hydrocodone. Patients are expected to take two pills a day, for a total cost of $31 a day.
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
3 days ago · The approval of suzetrigine is “an important public health milestone in acute pain management," Jacqueline Corrigan-Curay, JD, MD, acting director of the FDA Center for Drug …